Compounds > baclofen
Page last updated: 2024-10-23

baclofen and Cancer of Pituitary

baclofen has been researched along with Cancer of Pituitary in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Baclofen was unable to significantly rise serum PRL levels in healthy subjects and in patients affected by prolactinoma and furthermore did not interfere with PRL rise domperidone induced."1.27[Prolactin after baclofen in healthy subjects and prolactinoma patients]. ( Carletti, P; Ferretti, GF; Marchesi, GF; Morosini, PP; Nardi, B; Sarzani, R, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morosini, PP1
Carletti, P1
Sarzani, R1
Ferretti, GF1
Marchesi, GF1
Nardi, B1

Other Studies

1 other study available for baclofen and Cancer of Pituitary

ArticleYear
[Prolactin after baclofen in healthy subjects and prolactinoma patients].
    Bollettino della Societa italiana di biologia sperimentale, 1985, Jan-30, Volume: 61, Issue:1

    Topics: Adult; Baclofen; Cimetidine; Domperidone; Dopamine; Drug Interactions; Female; Humans; Hypothalamo-H

1985